/
/
/

Ajanta Pharma Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
12%14%13%17%
10%10%22%15%
10%20%28%40%
24%23%25%25%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
AJANTPHARM
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
3,549.2₹44554 Cr39.2626.66104.93₹1056 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹25 Cr₹25 Cr₹25 Cr₹25 Cr₹17 Cr₹17 Cr₹18 Cr₹18 Cr₹18 Cr₹18 Cr₹18 Cr₹18 Cr₹18 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr
₹3 Cr₹5 Cr₹6 Cr₹34 L₹30 L₹54 L₹47 L₹1 Cr₹2 Cr₹2 Cr₹27 L₹43 L₹58 L₹50 L₹0₹0₹0₹0₹0
₹4499 Cr₹3760 Cr₹3536 Cr₹3362 Cr₹3247 Cr₹2978 Cr₹2581 Cr₹2227 Cr₹2022 Cr₹1548 Cr₹1173 Cr₹823 Cr₹575 Cr₹381 Cr₹286 Cr₹217 Cr₹173 Cr₹145 Cr₹123 Cr
₹4499 Cr₹3760 Cr₹3536 Cr₹3362 Cr₹3247 Cr₹2978 Cr₹2581 Cr₹2227 Cr₹2022 Cr₹1548 Cr₹1173 Cr₹823 Cr₹575 Cr₹381 Cr₹286 Cr₹217 Cr₹173 Cr₹145 Cr₹123 Cr
₹4527 Cr₹3790 Cr₹3567 Cr₹3388 Cr₹3264 Cr₹2996 Cr₹2599 Cr₹2245 Cr₹2041 Cr₹1568 Cr₹1191 Cr₹841 Cr₹593 Cr₹393 Cr₹298 Cr₹229 Cr₹185 Cr₹157 Cr₹135 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹30 L
₹0₹0₹0₹1 Cr₹2 Cr₹2 Cr₹74 L₹66 L₹1 Cr₹1 Cr₹6 Cr₹23 Cr₹42 Cr₹58 Cr₹62 Cr₹48 Cr₹206 Cr₹211 Cr₹141 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹9 Cr₹10 Cr₹11 Cr₹16 Cr₹14 Cr₹11 Cr₹22 Cr₹39 Cr₹32 Cr
-₹71 Cr-₹76 Cr-₹26 Cr₹95 L₹46 Cr₹42 Cr₹56 Cr₹27 Cr₹24 Cr₹3 Cr₹11 Cr₹15 Cr₹23 Cr₹24 Cr₹17 Cr₹11 Cr₹5 Cr₹57 L-₹3 Cr
₹43 Cr₹38 Cr₹27 Cr₹29 Cr₹21 Cr₹23 Cr₹16 Cr₹33 L₹0₹9 L₹46 L₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹0₹0₹0
₹60 Cr₹80 Cr₹40 Cr₹147 Cr₹216 Cr₹208 Cr₹155 Cr₹134 Cr₹13 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹3 Cr₹5 Cr₹3 Cr₹0₹0₹0
₹33 Cr₹42 Cr₹41 Cr₹177 Cr₹285 Cr₹275 Cr₹228 Cr₹162 Cr₹39 Cr₹9 Cr₹29 Cr₹56 Cr₹81 Cr₹102 Cr₹101 Cr₹76 Cr₹233 Cr₹251 Cr₹171 Cr
₹544 Cr₹454 Cr₹463 Cr₹423 Cr₹327 Cr₹374 Cr₹362 Cr₹225 Cr₹250 Cr₹178 Cr₹146 Cr₹109 Cr₹125 Cr₹132 Cr₹101 Cr₹71 Cr₹69 Cr₹45 Cr₹43 Cr
₹629 Cr₹478 Cr₹370 Cr₹669 Cr₹301 Cr₹214 Cr₹180 Cr₹111 Cr₹64 Cr₹46 Cr₹57 Cr₹58 Cr₹48 Cr₹19 Cr₹43 Cr₹30 Cr₹7 L₹5 L₹4 L
₹207 Cr₹0₹0₹0₹0₹0₹43 Cr₹33 Cr₹0₹0₹46 Cr₹18 Cr₹61 Cr₹51 Cr₹95 Cr₹109 Cr₹0₹0₹0
₹307 Cr₹353 Cr₹63 Cr₹47 Cr₹19 Cr₹251 Cr₹160 Cr₹128 Cr₹32 Cr₹22 Cr₹11 Cr₹64 Cr₹43 Cr₹20 Cr₹10 Cr₹8 Cr₹8 Cr₹6 Cr₹9 Cr
₹1687 Cr₹1285 Cr₹895 Cr₹1139 Cr₹647 Cr₹839 Cr₹746 Cr₹498 Cr₹346 Cr₹247 Cr₹260 Cr₹250 Cr₹275 Cr₹222 Cr₹250 Cr₹218 Cr₹77 Cr₹51 Cr₹51 Cr
₹6247 Cr₹5117 Cr₹4504 Cr₹4705 Cr₹4197 Cr₹4109 Cr₹3572 Cr₹2906 Cr₹2426 Cr₹1823 Cr₹1479 Cr₹1146 Cr₹949 Cr₹718 Cr₹649 Cr₹522 Cr₹495 Cr₹459 Cr₹357 Cr
₹8 Cr₹8 Cr₹4 Cr₹4 Cr₹7 Cr₹82 Cr₹49 Cr₹46 Cr₹10 Cr₹12 Cr₹18 Cr₹5 Cr₹2 Cr₹3 Cr₹73 Cr₹52 Cr₹17 Cr₹33 Cr₹16 Cr
₹212 Cr₹3 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹46 Cr₹36 Cr₹2 Cr₹1 Cr₹81 Cr₹72 Cr₹130 Cr₹125 Cr₹200 Cr₹191 Cr₹228 Cr₹250 Cr₹174 Cr
₹3046 Cr₹2801 Cr₹2389 Cr₹2283 Cr₹2207 Cr₹2130 Cr₹1965 Cr₹1579 Cr₹1417 Cr₹895 Cr₹716 Cr₹550 Cr₹492 Cr₹438 Cr₹378 Cr₹313 Cr₹243 Cr₹192 Cr₹142 Cr
₹1179 Cr₹1039 Cr₹910 Cr₹786 Cr₹703 Cr₹598 Cr₹502 Cr₹411 Cr₹365 Cr₹306 Cr₹265 Cr₹262 Cr₹213 Cr₹166 Cr₹132 Cr₹99 Cr₹74 Cr₹54 Cr₹40 Cr
₹1867 Cr₹1762 Cr₹1479 Cr₹1496 Cr₹1504 Cr₹1532 Cr₹1463 Cr₹1168 Cr₹1053 Cr₹589 Cr₹451 Cr₹288 Cr₹279 Cr₹273 Cr₹246 Cr₹214 Cr₹168 Cr₹138 Cr₹102 Cr
₹258 Cr₹176 Cr₹256 Cr₹209 Cr₹153 Cr₹108 Cr₹132 Cr₹262 Cr₹61 Cr₹253 Cr₹198 Cr₹155 Cr₹88 Cr₹12 Cr₹3 Cr₹17 Cr₹47 Cr₹55 Cr₹24 Cr
₹29 Cr₹25 Cr₹19 Cr₹25 Cr₹25 Cr₹0₹12 Cr₹13 Cr₹8 Cr₹0₹0₹40 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr
₹29 Cr₹25 Cr₹19 Cr₹25 Cr₹25 Cr₹0₹12 Cr₹13 Cr₹8 Cr₹0₹0₹40 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr
₹85 Cr₹18 Cr₹14 Cr₹135 Cr₹236 Cr₹231 Cr₹166 Cr₹148 Cr₹77 Cr₹42 Cr₹21 Cr₹9 Cr₹39 Cr₹49 Cr₹51 Cr₹34 Cr₹0₹0₹0
₹2 Cr₹4 Cr₹4 Cr₹5 Cr₹6 Cr₹11 Cr₹9 Cr₹4 Cr₹4 Cr₹2 Cr₹4 Cr₹5 Cr₹9 Cr₹7 Cr₹1 Cr₹3 Cr₹0₹0₹0
₹2240 Cr₹1985 Cr₹1773 Cr₹1871 Cr₹1932 Cr₹1891 Cr₹1791 Cr₹1605 Cr₹1202 Cr₹973 Cr₹716 Cr₹513 Cr₹429 Cr₹349 Cr₹309 Cr₹277 Cr₹224 Cr₹202 Cr₹134 Cr
₹560 Cr₹439 Cr₹330 Cr₹510 Cr₹122 Cr₹176 Cr₹67 Cr₹65 Cr₹182 Cr₹182 Cr₹77 Cr₹19 Cr₹55 Cr₹0₹0₹0₹0₹0₹0
₹939 Cr₹904 Cr₹828 Cr₹816 Cr₹791 Cr₹766 Cr₹496 Cr₹436 Cr₹351 Cr₹211 Cr₹205 Cr₹159 Cr₹155 Cr₹148 Cr₹168 Cr₹113 Cr₹120 Cr₹104 Cr₹93 Cr
₹1854 Cr₹1183 Cr₹1247 Cr₹1057 Cr₹1020 Cr₹738 Cr₹775 Cr₹459 Cr₹460 Cr₹323 Cr₹372 Cr₹259 Cr₹202 Cr₹150 Cr₹141 Cr₹104 Cr₹97 Cr₹100 Cr₹87 Cr
₹105 Cr₹176 Cr₹131 Cr₹331 Cr₹212 Cr₹210 Cr₹205 Cr₹101 Cr₹93 Cr₹70 Cr₹43 Cr₹137 Cr₹60 Cr₹46 Cr₹11 Cr₹12 Cr₹15 Cr₹8 Cr₹6 Cr
₹53 Cr₹39 Cr₹54 Cr₹22 Cr₹35 Cr₹52 Cr₹55 Cr₹97 Cr₹115 Cr₹9 Cr₹3 Cr₹12 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹0₹0₹0
₹497 Cr₹378 Cr₹132 Cr₹89 Cr₹85 Cr₹276 Cr₹183 Cr₹143 Cr₹23 Cr₹56 Cr₹64 Cr₹47 Cr₹44 Cr₹21 Cr₹16 Cr₹14 Cr₹40 Cr₹45 Cr₹37 Cr
₹4007 Cr₹3119 Cr₹2722 Cr₹2825 Cr₹2264 Cr₹2218 Cr₹1781 Cr₹1301 Cr₹1224 Cr₹851 Cr₹763 Cr₹633 Cr₹520 Cr₹369 Cr₹340 Cr₹246 Cr₹271 Cr₹257 Cr₹223 Cr
₹2320 Cr₹1834 Cr₹1827 Cr₹1686 Cr₹1617 Cr₹1379 Cr₹1036 Cr₹802 Cr₹878 Cr₹604 Cr₹503 Cr₹384 Cr₹245 Cr₹147 Cr₹89 Cr₹28 Cr₹194 Cr₹206 Cr₹172 Cr
₹6247 Cr₹5117 Cr₹4504 Cr₹4705 Cr₹4197 Cr₹4109 Cr₹3572 Cr₹2906 Cr₹2426 Cr₹1823 Cr₹1479 Cr₹1146 Cr₹949 Cr₹718 Cr₹649 Cr₹522 Cr₹495 Cr₹459 Cr₹357 Cr
₹362₹303₹283₹269₹382₹346₹298₹257₹232₹178₹135₹96₹169₹168₹254₹195₹158₹134₹115
₹362₹303₹283₹269₹255₹231₹199₹171₹155₹119₹90₹64₹45₹30₹23₹17₹14₹12₹10

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹1378 Cr₹1189 Cr₹1114 Cr₹745 Cr₹909 Cr₹900 Cr₹664 Cr₹514 Cr₹623 Cr₹648 Cr₹559 Cr₹456 Cr₹330 Cr₹164 Cr₹91 Cr₹56 Cr₹39 Cr₹30 Cr₹29 Cr
₹163 Cr₹112 Cr₹83 Cr₹131 Cr₹92 Cr₹115 Cr₹71 Cr₹62 Cr₹52 Cr₹86 Cr₹53 Cr₹51 Cr₹51 Cr₹65 Cr₹51 Cr₹43 Cr₹40 Cr₹38 Cr₹26 Cr
-₹653 Cr₹179 Cr-₹100 Cr₹67 Cr-₹200 Cr-₹209 Cr-₹123 Cr-₹83 Cr-₹254 Cr₹26 Cr-₹124 Cr-₹82 Cr-₹75 Cr₹39 Cr-₹55 Cr₹6 Cr₹22 Cr-₹28 Cr-₹33 Cr
₹888 Cr₹1480 Cr₹1097 Cr₹943 Cr₹801 Cr₹807 Cr₹612 Cr₹493 Cr₹421 Cr₹760 Cr₹488 Cr₹426 Cr₹306 Cr₹267 Cr₹88 Cr₹105 Cr₹100 Cr₹40 Cr₹22 Cr
₹529 Cr₹1157 Cr₹785 Cr₹792 Cr₹562 Cr₹576 Cr₹457 Cr₹375 Cr₹281 Cr₹609 Cr₹326 Cr₹279 Cr₹212 Cr₹234 Cr₹70 Cr₹95 Cr₹95 Cr₹35 Cr₹19 Cr
-₹429 Cr-₹377 Cr₹65 Cr-₹560 Cr-₹74 Cr-₹282 Cr-₹224 Cr-₹223 Cr-₹256 Cr-₹383 Cr-₹209 Cr-₹158 Cr-₹188 Cr-₹104 Cr-₹53 Cr-₹51 Cr-₹43 Cr-₹82 Cr-₹59 Cr
-₹168 Cr-₹733 Cr-₹1051 Cr-₹108 Cr-₹460 Cr-₹318 Cr-₹129 Cr-₹147 Cr-₹20 L-₹202 Cr-₹117 Cr-₹105 Cr-₹20 Cr-₹104 Cr-₹13 Cr-₹56 Cr-₹46 Cr₹50 Cr₹38 Cr
-₹68 Cr₹47 Cr-₹201 Cr₹124 Cr₹28 Cr-₹24 Cr₹104 Cr₹4 Cr₹25 Cr₹24 Cr-₹25 L₹16 Cr₹4 Cr₹26 Cr₹4 Cr-₹11 Cr₹7 Cr₹2 Cr-₹2 Cr
₹175 Cr₹129 Cr₹330 Cr₹206 Cr₹178 Cr₹202 Cr₹95 Cr₹91 Cr₹66 Cr₹41 Cr₹42 Cr₹39 Cr₹34 Cr₹8 Cr₹4 Cr₹15 Cr₹8 Cr₹6 Cr₹7 Cr
₹107 Cr₹177 Cr₹129 Cr₹331 Cr₹205 Cr₹178 Cr₹199 Cr₹95 Cr₹91 Cr₹66 Cr₹41 Cr₹54 Cr₹39 Cr₹34 Cr₹8 Cr₹4 Cr₹15 Cr₹8 Cr₹6 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)3,521.10
Volume (₹)37,012.00
High (₹)3,594.00
Upper Circuit4,281.70
Low (₹)3,521.10
Lower Circuit2,854.50
Prev Close3,568.10
52W High (₹)3,796.00
Price3,549.20
52W Low (₹)2,329.90

Share Market Cap & Key Ratios Overview

M.Cap (₹)44553.50 Cr
Div. Yield (%)0.79
PE Ratio39.26
Debt to Equity0.05
Price to Book7.74
Book Value362.19
EPS (TTM)90.82
Face Value2.00
ROE (%)25.42

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
AJANTPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
3549.2-14.4 (-0.40%)
3465.80
3594
44,554Cr

Ajanta Pharma Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹494.48Cr; with other income of ₹70.9Cr, profit before interest and tax came to ₹449.98Cr. Interest expense was ₹3.18Cr; PBT before exceptional items stood at ₹446.8Cr. Cost mix (full year): raw materials ₹958.29Cr; employee cost ₹1291.15Cr; depreciation ₹44.5Cr; other expenses ₹1202.38Cr. Basis: consolidated annual results.

Ajanta Pharma Ltd Quaterly Results Key Takeaways

Ajanta Pharma Ltd reported ₹1625.96Cr total income from operations in Jun 2026, softer than ₹1421.64Cr in Mar 2026 but higher than ₹1302.65Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹494.48Cr; with other income of ₹70.9Cr, profit before interest and tax came to ₹449.98Cr. Interest expense was ₹3.18Cr, taking profit before tax to ₹446.8Cr. After tax of ₹112.58Cr, profit after tax stood at ₹334.22Cr (vs ₹266.7Cr in Mar 2026 and ₹255.34Cr in Jun 2025).